Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab176216 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Ladiratuzumab (anti-SLC39A6)
- Antibody type
- Recombinant
- Description
- Ladiratuzumab (anti-SLC39A6) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab (anti-SLC39A6), conjugated with the microtubule disrupting agent, MMAE to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab (anti-SLC39A6) can be used for research of breast cancer.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Ladiratuzumab (anti-SLC39A6) (Ab176216) - Flow Cytometry Flow Cytometry analysis of MCF-7 cells labelling SLC39A6 (red) with Ladiratuzumab (anti-SLC39A6) (Ab176216). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.